» Articles » PMID: 38969714

Exploring the Potential of Predicted MiRNAs on the Genes Involved in the Expansion of Hematopoietic Stem Cells

Overview
Journal Sci Rep
Specialty Science
Date 2024 Jul 5
PMID 38969714
Authors
Affiliations
Soon will be listed here.
Abstract

A major challenge in therapeutic approaches applying hematopoietic stem cells (HSCs) is the cell quantity. The primary objective of this study was to predict the miRNAs and anti-miRNAs using bioinformatics tools and investigate their effects on the expression levels of key genes predicted in the improvement of proliferation, and the inhibition of differentiation in HSCs isolated from Human umbilical cord blood (HUCB). A network including genes related to the differentiation and proliferation stages of HSCs was constructed by enriching data of text (PubMed) and StemChecker server with KEGG signaling pathways, and was improved using GEO datasets. Bioinformatics tools predicted a profile from miRNAs containing miR-20a-5p, miR-423-5p, and chimeric anti-miRNA constructed from 5'-miR-340/3'-miR-524 for the high-score genes (RB1, SMAD4, STAT1, CALML4, GNG13, and CDKN1A/CDKN1B genes) in the network. The miRNAs and anti-miRNA were transferred into HSCs using polyethylenimine (PEI). The gene expression levels were estimated using the RT-qPCR technique in the PEI + (miRNA/anti-miRNA)-contained cell groups (n = 6). Furthermore, CD markers (90, 16, and 45) were evaluated using flow cytometry. Strong relationships were found between the high-score genes, miRNAs, and chimeric anti-miRNA. The RB1, SMAD4, and STAT1 gene expression levels were decreased by miR-20a-5p (P < 0.05). Additionally, the anti-miRNA increased the gene expression level of GNG13 (P < 0.05), whereas the miR-423-5p decreased the CDKN1A gene expression level (P < 0.01). The cellular count also increased significantly (P < 0.05) but the CD45 differentiation marker did not change in the cell groups. The study revealed the predicted miRNA/anti-miRNA profile expands HSCs isolated from HUCB. While miR-20a-5p suppressed the RB1, SMAD4, and STAT1 genes involved in cellular differentiation, the anti-miRNA promoted the GNG13 gene related to the proliferation process. Notably, the mixed miRNA/anti-miRNA group exhibited the highest cellular expansion. This approach could hold promise for enhancing the cell quantity in HSC therapy.

References
1.
Ren Y, Cui Y, Wang H . Effects of different concentrations of nicotinamide on hematopoietic stem cells cultured . World J Stem Cells. 2024; 16(2):163-175. PMC: 10915957. DOI: 10.4252/wjsc.v16.i2.163. View

2.
Kimura T, Yamazaki S . [Development of low-cost ex vivo hematopoietic stem cell expansion]. Rinsho Ketsueki. 2022; 63(10):1422-1429. DOI: 10.11406/rinketsu.63.1422. View

3.
Papa L, Djedaini M, Hoffman R . Ex vivo HSC expansion challenges the paradigm of unidirectional human hematopoiesis. Ann N Y Acad Sci. 2019; 1466(1):39-50. PMC: 7216880. DOI: 10.1111/nyas.14133. View

4.
Lin J, Huang S, Wu S, Ding J, Zhao Y, Liang L . MicroRNA-423 promotes cell growth and regulates G(1)/S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma. Carcinogenesis. 2011; 32(11):1641-7. DOI: 10.1093/carcin/bgr199. View

5.
Tonelli F, Santos A, Gomes D, L da Silva S, Gomes K, Ladeira L . Stem cells and calcium signaling. Adv Exp Med Biol. 2012; 740:891-916. PMC: 3979962. DOI: 10.1007/978-94-007-2888-2_40. View